J-D de Korwin-Krokowski

Imatinib mesylate in scleroderma‐associated diffuse skin fibrosis: a phase II multicentre randomized double‐blinded controlled trial

S. Lepreux, E. Hachulla, S. Prey, 2012, The British journal of dermatology.